The monkeypox vaccine, developed at the National Research Center for Epidemiology and Microbiology named after NF Gamaleya, should give people lifelong immunity against the disease. He writes about it TASS referring to the institution’s director, Alexander Ginzburg.
He noted that the mentioned effect can only be achieved with a properly made drug “on a good carrier such as genetically modified adenovirus”. Another condition in this case is the absence of antigenic drift in the causative agent of the infectious disease, such as influenza and COVID-19.
Asked whether people should be revaccinated against monkeypox, the expert replied: “I think immunity should last a lifetime, but this of course needs to be checked.”
According to Gunzburg, the same thing will happen with vaccination against monkeypox and vaccination against coronavirus. We are talking about those who were vaccinated with the original version of Sputnik V against the so-called “Wuhan” strain.
As the director of the NF Gamaleya Center said, in almost four years the number of antibodies in the body of such people went “off scale.” He concluded that the same could happen with vaccines against monkeypox or smallpox.
Previously at the World Health Organization spoke On wearing a mask amid a monkeypox outbreak.